Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Suzhou Tongli Biological Medicine Co., Ltd.
0 Patents (Medical) associated with Suzhou Tongli Biological Medicine Co., Ltd.
100 Deals associated with Suzhou Tongli Biological Medicine Co., Ltd.
100 Translational Medicine associated with Suzhou Tongli Biological Medicine Co., Ltd.